pharma
Swedish firm in Chinese HIV deal
Swedish biotech company Medivir has licensed development of its HIV drug MIV-160 to Chinese company Guangdong Lantai Viewland Pharmaceuticals.
Swedish biotech company Medivir has licensed development of its HIV drug MIV-160 to Chinese company Guangdong Lantai Viewland Pharmaceuticals.